Lack of macrophage migration inhibitory factor protects mice against concanavalin A‐induced liver injury

Abstract

A lack of MIF protected the mice from Con A-induced liver injury. Controlling the MIF activity may be a useful therapeutic strategy for treating such T-cell activation-associated liver diseases as autoimmune hepatitis and viral hepatitis.